The Jeffrey Modell Foundation funds innovative research and physician education to improve the diagnosis, treatment, and understanding of Primary Immunodeficiency (PI) worldwide.
Funder: Jeffrey Modell Foundation
Due Dates: March 13, 2026 (Letter of Intent, Translational Research Program) | July 24, 2026 (Full application, invited investigators)
Funding Amounts: Up to $250,000 over two years (Translational Research); up to $50,000 over two years (Specific Defect); up to $25,000/year for two years (C.H.I.L.D.R.E.N!); direct costs only, no overhead.
Summary: Supports innovative translational research, immune defect studies, and physician education to advance Primary Immunodeficiency (PI) diagnosis and treatment globally.
Key Information: Letter of Intent required for Translational Research Program; other programs accept applications on a rolling basis.
The Jeffrey Modell Foundation’s Research & Education Grants fund a range of projects designed to advance the understanding, diagnosis, and treatment of Primary Immunodeficiency (PI). These grants support innovative translational research, investigation of specific immune system defects, research to improve outcomes for children with PI, and physician education initiatives. The overarching aim is to bridge basic scientific discoveries with clinical applications, improve early diagnosis, develop novel therapies, and foster global collaboration in PI research and care.
Grants are available through several programs: